Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-07-16

Clinical Trial Update: Phase 3, Febuxostat, Allopurinol and Placebo-Controlled Study in Gout Subjects. [Phase 3]

View source ↗

Summary

A Phase 3, randomized, placebo-controlled trial comparing febuxostat and allopurinol in gout subjects has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Allopurinol (Allopurinol)
  • FEBUXOSTAT (Febuxostat)

Snippet

Sponsor: Takeda | Conditions: Gout | Phase 3 | Status: COMPLETED | Results posted: 2009-07-16